In our experiments, subcutaneous tumour grafting and orthotopic EC models demonstrated that HMGA1 interference or gene knockout significantly inhibited EC tumorigenesis, an effect that was further enhanced by olaparib treatment. The gene discussed is HMGA1; the disease is neoplasm.